2020
DOI: 10.1016/j.biopha.2020.109865
|View full text |Cite
|
Sign up to set email alerts
|

miR-6089/MYH9/β-catenin/c-Jun negative feedback loop inhibits ovarian cancer carcinogenesis and progression

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

5
31
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
10

Relationship

1
9

Authors

Journals

citations
Cited by 45 publications
(36 citation statements)
references
References 54 publications
5
31
0
Order By: Relevance
“…RNA pull-down assays combined with MS and WB identified MHY9. In the literature, MYH9 has been described as a strong EMT inducer that promotes the progression of various cancers [33][34][35][36]. Here, our experiments confirmed that MYH9 is also expressed in RPE cells.…”
Section: Discussionsupporting
confidence: 87%
“…RNA pull-down assays combined with MS and WB identified MHY9. In the literature, MYH9 has been described as a strong EMT inducer that promotes the progression of various cancers [33][34][35][36]. Here, our experiments confirmed that MYH9 is also expressed in RPE cells.…”
Section: Discussionsupporting
confidence: 87%
“…Dysregulation of miRNAs is established to be involved in the many diseases. miR-6089 serves a tumorsuppressive miRNA in ovarian cancer, which directly targets MYH9 to inactivate the Wnt/β-catenin and its downstream EMT [17]. In our study, we proved that miR-6089 was signi cantly decreased in synovial tissues and FLS of RA patients compared with health donor.…”
Section: Discussionsupporting
confidence: 52%
“…The Wnt signaling cascade was highly conserved among species and controls a multitude of biological processes during animal development and life cycles. Because of its central role in the maintenance of tissue homeostasis, the Wnt pathway was tightly regulated at multiple levels, from the ligand-receptor interaction down to transcriptional and post-transcriptional levels; its aberrant activity has been implicated in a number of developmental disorders and diseases and, most prominently, in cancer (Nusse and Clevers, 2017;Nguyen et al, 2019;Zhang et al, 2019;Liu et al, 2020). The recent discovery of lncRNAs that are regulated by Wnt and/or participate in Wnt pathway modulation and outcome is particularly intriguing and has highlighted some of these gaps in our knowledge (Zarkou et al, 2018).…”
Section: Regulatory Mechanism Of Linc-ror In Various Types Of Cancermentioning
confidence: 99%